311 related articles for article (PubMed ID: 21645209)
1. Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma.
Decaens T; Roudot-Thoraval F; Badran H; Wolf P; Durand F; Adam R; Boillot O; Vanlemmens C; Gugenheim J; Dharancy S; Bernard PH; Boudjema K; Calmus Y; Hardwigsen J; Ducerf C; Pageaux GP; Hilleret MN; Chazouillères O; Cherqui D; Mallat A; Duvoux C
Liver Int; 2011 Jul; 31(6):792-801. PubMed ID: 21645209
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria.
Duvoux C; Roudot-Thoraval F; Decaens T; Pessione F; Badran H; Piardi T; Francoz C; Compagnon P; Vanlemmens C; Dumortier J; Dharancy S; Gugenheim J; Bernard PH; Adam R; Radenne S; Muscari F; Conti F; Hardwigsen J; Pageaux GP; Chazouillères O; Salame E; Hilleret MN; Lebray P; Abergel A; Debette-Gratien M; Kluger MD; Mallat A; Azoulay D; Cherqui D;
Gastroenterology; 2012 Oct; 143(4):986-94.e3; quiz e14-5. PubMed ID: 22750200
[TBL] [Abstract][Full Text] [Related]
3. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
[TBL] [Abstract][Full Text] [Related]
4. Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score.
Marelli L; Grasso A; Pleguezuelo M; Martines H; Stigliano R; Dhillon AP; Patch D; Davidson BR; Sharma D; Rolles K; Burroughs AK
Ann Surg Oncol; 2008 Dec; 15(12):3503-11. PubMed ID: 18777193
[TBL] [Abstract][Full Text] [Related]
5. Living donor liver transplantation for hepatocellular carcinoma.
Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S
Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251
[TBL] [Abstract][Full Text] [Related]
6. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
Zavaglia C; De Carlis L; Alberti AB; Minola E; Belli LS; Slim AO; Airoldi A; Giacomoni A; Rondinara G; Tinelli C; Forti D; Pinzello G
Am J Gastroenterol; 2005 Dec; 100(12):2708-16. PubMed ID: 16393224
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays.
Shim JH; Lee HC; Han S; Kang HJ; Yu E; Lee SG
Liver Transpl; 2013 Mar; 19(3):336-45. PubMed ID: 23203386
[TBL] [Abstract][Full Text] [Related]
8. Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma.
de Ataide EC; Garcia M; Mattosinho TJ; Almeida JR; Escanhoela CA; Boin IF
Transplant Proc; 2012 Oct; 44(8):2438-40. PubMed ID: 23026614
[TBL] [Abstract][Full Text] [Related]
9. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
11. Delta-slope of alpha-fetoprotein improves the ability to select liver transplant patients with hepatocellular cancer.
Lai Q; Inostroza M; Rico Juri JM; Goffette P; Lerut J
HPB (Oxford); 2015 Dec; 17(12):1085-95. PubMed ID: 26373980
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for hepatocellular carcinoma recurrence: experience with 83 liver transplantation patients.
Ataide EC; Boin IF; Almeida JR; Sevá-Pereira T; Stucchi RS; Cardoso AR; Caruy CA; Escanhoela CA
Transplant Proc; 2011 May; 43(4):1362-4. PubMed ID: 21620130
[TBL] [Abstract][Full Text] [Related]
13. Extended criteria for living donor liver transplantation in patients with advanced hepatocellular carcinoma.
Choi HJ; Kim DG; Na GH; Hong TH; You YK
Transplant Proc; 2012 Mar; 44(2):399-402. PubMed ID: 22410027
[TBL] [Abstract][Full Text] [Related]
14. How to select suitable hepatocellular carcinoma for liver transplantation by preoperative neutrophil-lymphocyte ratio.
Xiao GQ; Yan L; Yang J
Hepatogastroenterology; 2014 Oct; 61(135):2077-83. PubMed ID: 25713913
[TBL] [Abstract][Full Text] [Related]
15. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.
Tamura S; Kato T; Berho M; Misiakos EP; O'Brien C; Reddy KR; Nery JR; Burke GW; Schiff ER; Miller J; Tzakis AG
Arch Surg; 2001 Jan; 136(1):25-30; discussion 31. PubMed ID: 11146770
[TBL] [Abstract][Full Text] [Related]
16. Effects of risk factors and Ki-67 on rates of recurrence on patients who have undergone liver transplant for hepatocellular carcinoma.
Aktas S; Karakayali H; Moray G; Ozdemir H; Haberal M
Transplant Proc; 2011 Dec; 43(10):3807-12. PubMed ID: 22172851
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
[TBL] [Abstract][Full Text] [Related]
18. Identifying patients at higher risk of hepatocellular carcinoma recurrence after liver transplantation in a multicenter cohort study from Argentina.
Piñero F; Marciano S; Anders M; Orozco Ganem F; Zerega A; Cagliani J; Andriani O; de Santibañes E; Gil O; Podestá LG; McCormack L; Gadano A; Silva M
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):421-7. PubMed ID: 26684693
[TBL] [Abstract][Full Text] [Related]
19. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?
Chan AC; Chan SC; Chok KS; Cheung TT; Chiu DW; Poon RT; Fan ST; Lo CM
Liver Transpl; 2013 Apr; 19(4):411-9. PubMed ID: 23447460
[TBL] [Abstract][Full Text] [Related]
20. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival.
Moon JI; Kwon CH; Joh JW; Choi GS; Jung GO; Kim JM; Shin M; Choi SJ; Kim SJ; Lee SK
Transplant Proc; 2012 Mar; 44(2):487-93. PubMed ID: 22410053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]